Jan 3 (Reuters) - Myokardia Inc :
* Myokardia Inc - Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration formed in August 2014
* Myokardia Inc - Myokardia is now eligible for a $45 million milestone payment payable by January 31, 2017.
* Myokardia Inc - intends to initiate a phase 1 study of MYK-491 in healthy volunteers in first half of 2017. Source text for Eikon: Further company coverage: